Suppr超能文献

在慢性心力衰竭患者的稳定期,脑钠肽(BNP)和N末端脑钠肽原(NT-proBNP)每周出现不明原因变化的情况较少。

Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state.

作者信息

Schou Morten, Gustafsson Finn, Nielsen Per H, Madsen Lene H, Kjaer Andreas, Hildebrandt Per R

机构信息

Department of Cardiology and Endocrinology, Clinic E, Frederiksberg University Hospital, Ndr. Fasanvej 57-59, DK-2000-Frederiksberg, Denmark.

出版信息

Eur J Heart Fail. 2007 Jan;9(1):68-74. doi: 10.1016/j.ejheart.2006.05.001. Epub 2006 Jul 7.

Abstract

BACKGROUND

The usefulness of brain-natriuretic-peptide (BNP) and N-terminal-pro-brain-natriuretic-peptide (NT-proBNP) for monitoring of chronic heart failure (CHF) patients has been questioned because of high levels of unexplained variation.

AIMS

Week-to-week total variance (CV(T)), unexplained variation (CV(I)), reference change values (RCV), index of individualities (IOI) and number of samples (N) with week-to-week intervals needed to estimate the underlying homeostatic set point (+/-15%) for BNP and NT-proBNP were calculated in pre-specified stable CHF patients.

METHODS AND RESULTS

We measured plasma concentrations of BNP and NT-proBNP, clinical and laboratory variables in 20 CHF patients with a 7-days interval. Only patients considered to be in steady state were included. The CV(I) was 15% (BNP) and 8% (NT-proBNP). CV(T) was 16% (BNP) and 8% (NT-proBNP) and RCV was 43% (BNP) and 23% (NT-proBNP). IOI was 0.14 for BNP and 0.03 for NT-proBNP and N was 1 for BNP and 1 for NT-proBNP.

CONCLUSIONS

Our data demonstrate that unexplained variation of BNP and NT-proBNP is low in CHF patients during steady state, which is a prerequisite for the use of these peptides for monitoring of the disease.

摘要

背景

由于存在高水平的无法解释的变异,脑钠肽(BNP)和N末端脑钠肽原(NT-proBNP)用于监测慢性心力衰竭(CHF)患者的效用受到质疑。

目的

计算预先指定的稳定CHF患者中BNP和NT-proBNP的每周总变异(CV(T))、无法解释的变异(CV(I))、参考变化值(RCV)、个体指数(IOI)以及估计基础稳态设定点(±15%)所需的每周间隔样本数(N)。

方法与结果

我们以7天为间隔测量了20例CHF患者的血浆BNP和NT-proBNP浓度、临床及实验室变量。仅纳入被认为处于稳定状态的患者。CV(I)为15%(BNP)和8%(NT-proBNP)。CV(T)为16%(BNP)和8%(NT-proBNP),RCV为43%(BNP)和23%(NT-proBNP)。BNP的IOI为0.14,NT-proBNP的IOI为0.03,BNP的N为1,NT-proBNP的N为1。

结论

我们的数据表明,在稳定状态下CHF患者中BNP和NT-proBNP的无法解释的变异较低,这是使用这些肽监测该疾病的前提条件。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验